Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in CashChange in InventoryChange in ReceivablesChange in Working CapitalDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

MDxHealth (MDXH) Cash from Investing Activities: 2021-2025

Historic Cash from Investing Activities for MDxHealth (MDXH) over the last 4 years, with Sep 2025 value amounting to $1.7 million.

  • MDxHealth's Cash from Investing Activities rose 129.58% to $1.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$5.2 million, marking a year-over-year increase of 88.30%. This contributed to the annual value of -$1.6 million for FY2024, which is 58.38% up from last year.
  • MDxHealth's Cash from Investing Activities amounted to $1.7 million in Q3 2025, which was up 204.07% from -$1.6 million recorded in Q2 2025.
  • MDxHealth's Cash from Investing Activities' 5-year high stood at $13.8 million during Q4 2024, with a 5-year trough of -$17.0 million in Q3 2021.
  • For the 2-year period, MDxHealth's Cash from Investing Activities averaged around $1.1 million, with its median value being -$1.6 million (2025).
  • In the last 5 years, MDxHealth's Cash from Investing Activities fell by 29.63% in 2022 and then skyrocketed by 129.58% in 2025.
  • MRQ analysis of 4 years shows MDxHealth's Cash from Investing Activities stood at -$17.0 million in 2021, then increased by 11.04% to -$15.1 million in 2022, then surged by 191.29% to $13.8 million in 2024, then plummeted by 87.94% to $1.7 million in 2025.
  • Its Cash from Investing Activities stands at $1.7 million for Q3 2025, versus -$1.6 million for Q2 2025 and -$2.6 million for Q1 2025.